Out of the three RAS isoforms (KRAS, NRAS, HRAS), KRAS is the most commonly mutated in approximately 95% of pancreatic cancers, 50% of colorectal cancers and 30% of lung cancers [61,62,63]. Here, KRAS is linked to familial pancreatic carcinoma.